Report Scope: This report provides a detailed description of flexible manufacturing systems in the pharmaceutical industry and the latest technologies in the market. The report includes market estimates for different types of flexible manufacturing systems and also includes recent technological developments and assessments of product performance in the market.
Based on the approach type, the flexible manufacturing systems in pharmaceutical industry is segmented into modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing.
Based on application, the market is segmented into manufacturing, aseptic filling and others (research and development, clinical research and academic research).
Based on industry, the market is segmented into pharmaceutical and biotechnology.
The report discusses the qualitative and quantitative factors influencing the market growth. The market drivers, restraints and opportunities are discussed in the report.
This report discusses some of the major drivers and restraints as well as the competition and key players’ strategies and performances.The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions.
The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report also provides insights on the market share and upcoming regional demand.
Some of the major market players discussed in the report are Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc. For market estimates, data have been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Report Includes: - 22 data tables and 20 additional tables - An overview of the global market for flexible manufacturing systems in the pharmaceutical industry - Estimation of the market size and analyses of the global market trends, with data from 2019, 2020, estimates for 2021 with projection of CAGR through 2026 - Market share analysis of flexible manufacturing systems based on approaches, industry type, application, and geography, and identification of new opportunities, challenges, and technological changes within the industry - Detailed description of flexible manufacturing system, its working, objectives, benefits, and limitations - Detailed analysis of the regulatory framework and policies, reimbursement scenarios and key product and technology developments - Identification of economic and demographic factors affecting the market growth and market insights about the future of the industry - Information on quicker approval processes of regulatory authorities for the new drugs, and initiatives by international organizations to improve flexible manufacturing systems - Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies - Company profiles of major players in the market, including Cytiva, Jacobs Engineering Inc., Exyte GmbH, G-CON Manufacturing, KeyPlants AB and Germfree Laboratories Inc.
Summary: The global market for flexible manufacturing systems in the pharmaceutical industry was worth $REDACTED billion in 2020.The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion by 2026.
Increased emphasis on lowering manufacturing costs and unpredictable demand for different products, demands more flexible and agile facilities is one of the key factors driving the market. The need for process optimization and improvements in the supply chain are driving investment in automation technologies across the pharmaceutical industry, and the current rise in demand for biopharmaceuticals due to COVID-19 has driven the need for strategic changes in bioprocessing.
Reasons for Doing This Study: The global biopharmaceutical market is changing consistently.Earlier, the main emphasis was on bestseller drugs manufactured in large amounts.
Now, the focus has changed towards a greater number of products manufactured in smaller batches.With revenues under pressure, biopharmaceutical companies are confronting growing demands to develop new drugs at a lesser cost in an ever-declining time frame.
Innovative tools and technologies that streamline operations and decrease process time can create opportunities to improve annual batch throughput.Advanced approaches that challenge conventional upstream and downstream process approaches help increase facility utilization and flexibility.
Thus, unpredictable demand coupled with volatile market behavior and a growing focus on reducing manufacturing costs for different products drives the need for more flexible and agile facilities in the pharmaceutical industry.
Different approaches of flexible manufacturing systems in the pharmaceutical industry are discussed in the report such as modular manufacturing, data-driven manufacturing, single-use manufacturing, and continuous manufacturing.
The study also highlights the potential growth of the market. The research will provide a detailed overview of the market players, market shares, partnerships, mergers and acquisitions, and financials.
Our reports have been used by over 10K customers, including:
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Enterprise ICT Investment Trends in Pharmaceuticals Sector, 2021 Update Summary According to Information & Communication Technology (ICT) decision makers survey, the largest share of enterprise ICT budget in the pharmaceuticals sector for 2020 was allocated to ’production, procurement and operations’...
The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides...
Pharmaceutical Analytical Testing market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pharmaceutical Analytical Testing Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pharmaceutical Analytical Testing...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the desiccants market are Porocel, The Dow Chemical, INEOS, Fuji Silysia Chemical, and Hengye Molecular Sieve. The global desiccants market is expected to grow from $0.13 billion in 2020 to $0.14 billion in 2021 at a compound annual growth rate (CAGR) of 7.7%. The growth is mainly due to the companies resuming their...
The global cosmeceuticals market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Global Big Pharma Partnering Terms and Agreements 2014 to 2021 report provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides...
Global Specialty Pharmaceutical Partnering Terms and Agreements 2014 to 2021 report provides a detailed understanding and analysis of how and why companies enter Specialty Pharmaceutical partnering deals. This report provides details of the latest Specialty Pharmaceutical agreements announced in the life sciences since...
Retinoic Acid Receptor Gamma - Drugs In Development, 2021 Summary Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor gamma (RARG) is a nuclear receptor that is encoded by the RARG gene. RARG bind as heterodimers to the...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.